BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27886046)

  • 1. Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders.
    Meurk C; Ford P; Sharma R; Fitzgerald L; Gartner C
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27886046
    [No Abstract]   [Full Text] [Related]  

  • 2. Views and preferences of people living with HIV about smoking, quitting and use of nicotine products.
    Edwards S; Fitzgerald L; Mutch A; Dean JA; Ford P; Howard C; Watts P; Gartner C
    Int J Drug Policy; 2021 Nov; 97():103349. PubMed ID: 34252787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian urban Indigenous smokers' perspectives on nicotine products and tobacco harm reduction.
    Yuke K; Ford P; Foley W; Mutch A; Fitzgerald L; Gartner C
    Drug Alcohol Rev; 2018 Jan; 37(1):87-96. PubMed ID: 28493405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivations and Limitations Associated with Vaping among People with Mental Illness: A Qualitative Analysis of Reddit Discussions.
    Sharma R; Wigginton B; Meurk C; Ford P; Gartner CE
    Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28025516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm perceptions of e-cigarettes and other nicotine products in a UK sample.
    Wilson S; Partos T; McNeill A; Brose LS
    Addiction; 2019 May; 114(5):879-888. PubMed ID: 30609154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm perceptions of nicotine-containing products and associated sources of information in UK adults with and without mental ill health: A cross-sectional survey.
    Perman-Howe PR; Horton M; Robson D; McDermott MS; McNeill A; Brose LS
    Addiction; 2022 Mar; 117(3):715-729. PubMed ID: 34338387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smokers' and ex-smokers' understanding of electronic cigarettes: a qualitative study.
    Rooke C; Cunningham-Burley S; Amos A
    Tob Control; 2016 Apr; 25(e1):e60-6. PubMed ID: 26055267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention.
    Notley C; Ward E; Dawkins L; Holland R
    Harm Reduct J; 2018 Jun; 15(1):31. PubMed ID: 29921278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between Dual Users and Switchers Center around Vaping Behavior and Its Experiences Rather than Beliefs and Attitudes.
    Adriaens K; Van Gucht D; Baeyens F
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge about E-Cigarettes and Tobacco Harm Reduction among Public Health Residents in Europe.
    Ferrara P; Shantikumar S; Cabral Veríssimo V; Ruiz-Montero R; Masuet-Aumatell C; Ramon-Torrell JM;
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31212756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.
    Edwards S; Puljević C; Dean JA; Gilks C; Boyd MA; Baker P; Watts P; Howard C; Gartner CE
    AIDS Behav; 2023 Feb; 27(2):618-627. PubMed ID: 35869375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaping
    Rehan HS; Maini J; Hungin APS
    Curr Drug Saf; 2018; 13(2):92-101. PubMed ID: 29485005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.
    Morphett K; Puljević C; Borland R; Carter A; Hall W; Gartner C
    Int J Drug Policy; 2021 Feb; 88():103020. PubMed ID: 33161296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners' attitudes.
    Bell SK; Mena G; Dean J; Boyd M; Gilks C; Gartner C
    Drug Alcohol Depend; 2017 Aug; 177():67-70. PubMed ID: 28577393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoking and nicotine delivery alternatives: patterns of product use and perceptions in 13 countries.
    Riahi F; Rajkumar S; Yach D
    F1000Res; 2019; 8():80. PubMed ID: 31131094
    [No Abstract]   [Full Text] [Related]  

  • 17. Adolescents' and Young Adults' Perceptions of Electronic Cigarettes for Smoking Cessation: A Focus Group Study.
    Camenga DR; Cavallo DA; Kong G; Morean ME; Connell CM; Simon P; Bulmer SM; Krishnan-Sarin S
    Nicotine Tob Res; 2015 Oct; 17(10):1235-41. PubMed ID: 25646346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can e-cigarettes improve the well-being of people with mental health disorders?
    Brown JEH; Gartner C; Carter A
    Int J Drug Policy; 2019 Nov; 73():170-171. PubMed ID: 31350106
    [No Abstract]   [Full Text] [Related]  

  • 19. Why Don't More Smokers Switch to Using E-Cigarettes: The Views of Confirmed Smokers.
    McKeganey N; Dickson T
    Int J Environ Res Public Health; 2017 Jun; 14(6):. PubMed ID: 28621763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA's regulatory shift on tobacco control.
    Yang YT
    Prev Med; 2018 Aug; 113():153-155. PubMed ID: 29866276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.